Evidence map›Paper›PMID 23438731›Full record

ReviewMolecular & cellular proteomics : MCP2013

Toward a platform for comprehensive glycan sequencing.

Vernon Reinhold, Hailong Zhang, Andrew Hanneman, David Ashline

Abstract readReview
In one paragraph

Review in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Chemical science · 2023
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Lactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut.Journal of mammary gland biology and neoplasia · 2015
    Review
  13. Article
  14. Article
  15. Review
  16. Tools to MSn Sequence and Document the Structures of Glycan Epitopes.Discovering the subtleties of sugars : proceedings of the 3rd Beilstein Glyco-Bioinformatics Symposium : June 10th - 14th, 2013, Potsdam, Germany. International Beilstein Symposium on Glyco-Bioinformatics (3rd : 2013 : Potsdam, Germany) · 2014
    Article
  17. Article
  18. Review
  19. Review
  20. Glycoproteomic and glycomic databases.Clinical proteomics · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vernon ReinholdGlycomics Center, University of New Hampshire, Durham, New Hampshire 03824, USA. vnr@unh.edu
Hailong Zhang
Andrew Hanneman
David Ashline

Funding

REGULATION OF LACTOSAMINYL GLYCAN BIOSYNTHESIS IN HEMATOPOIETIC CELLSP01HL107146 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SACKSTEIN, ROBERT · 2011 to 2017
$17.7M
NHLBI NIH HHS P01 HL107146NHLBI NIH HHS P01 HL107146-01PHS HHS R01A1090866
6 · The paper itself

Abstract

From a series of recently published reports, an analytical platform has been proposed for a quantitative and qualitative measure of N- and O-glycosylation, complete with peptide-glycan connectivity and detailed structural understanding. As distant as this may appear, a best methods approach will appear that must move us beyond the cartoon stage of structural understanding. Thus, with this unifying goal in mind, we summarize a series of individually promising first phase protocols of sample preparation (release, purification, and quantification) that remain congruent with a concluding phase (methylation and MS(n)) for documented structural detail. Sequential enzymatic N-glycan and chemical O-glycan release from glycopeptides with intervening solid phase extraction and derivatization will provide for a comparative quantification measure of glycosylation. The O-glycan release will be nonreductive and coupled with Michael addition to a pyrazolone analog (1-phenyl-3-methyl-5-pyrazolone) with both the peptide and glycan labeled. The product glycans are stable to methylation and appropriate for sequential disassembly (MS(n)). An application using human serum and cancer samples has been detailed characterizing sLe(x) and comparable valence epitopes. This integrated platform will provide opportunities at variable points to contrast, share, and advance alternative protocols in a collaborative effort that is greatly needed. This integrated platform provides end point opportunities to confirm structural details compiled from synthetic standards and well characterized biologics by MS(n).

Indexed as

AnimalsCarbohydrate ConformationCarbohydrate SequenceCell Line, TumorGlycoproteinsGlycosylationHumansMolecular Sequence DataPolysaccharidesProtein Processing, Post-TranslationalSequence AnalysisStaining and LabelingTandem Mass SpectrometryGlycoproteinsPolysaccharides

Identifiers

PMID23438731
PMCPMC3617333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.